Western blotting revealed that XAV930 effectively reduced the activation of the Wnt/β-catenin pathway; however, this reduction effect was partially counteracted by the upregulation of CARM1 expression in BC cells (Figure 3G,H; Figure S9). Here, CARM1 is linked to breast cancer.